# Biological Product (except Diagnostic) Manufacturing (NAICS 325414)

Canonical: https://abierto.us/industries/325414

Federal contract opportunities under NAICS 325414. 27 opportunities in the window, 2 open now.

## Open now (2)

- Vivo?Efficacy of?Blood stable?Thiobenzamides? (75N98026Q01123), National Institutes of Health, due September 20, 2026 at 9:00 AM EDT. https://abierto.us/opportunities/75n98026q01123
- 2027 Southern Hemisphere Influenza Vaccine (SPE2DP26R0002), Defense Logistics Agency, due September 30, 2026 at 3:00 PM EDT. https://abierto.us/opportunities/spe2dp26r0002

## Recent (25 in all)

- September 11, 2026: Methylation Sequencing Library Preparation Kits fo (75N98026Q01200), presolicitation. https://abierto.us/opportunities/75n98026q01200
- September 4, 2026: Notice of Intent: Chromium GEM-X sequencing reagents (75N98026Q01149), presolicitation. https://abierto.us/opportunities/75n98026q01149
- August 28, 2026: Acquisition of an Agilent-BioTek Multimode Plate Reader (75N98026Q01117AGILENTTECHNOLOGIESPCANIDDK06663), presolicitation. https://abierto.us/opportunities/75n98026q01117agilenttechnologiespcaniddk06663
- August 26, 2026: Amyloid radiotracers for Baltimore Longitudinal Study of Aging (75N98026Q01057), combined synopsis and solicitation. https://abierto.us/opportunities/75n98026q01057
- August 26, 2026: Methylation Sequencing Library Preparation Kits f (75N98026Q01091), combined synopsis and solicitation. https://abierto.us/opportunities/75n98026q01091
- August 24, 2026: Injectable Influenza Vaccine (SPE2DP26R0003), sources sought. https://abierto.us/opportunities/spe2dp26r0003
- August 24, 2026: Injectable Egg-Free Influenza Vaccine 2027 (SPE2DP26R0004), sources sought. https://abierto.us/opportunities/spe2dp26r0004
- August 21, 2026: 30 vials of cryopreserved HepaRG cells (Catalog Number: HPRGC10) (75N98026Q01054), combined synopsis and solicitation, awarded to Life Technologies Corporation. https://abierto.us/opportunities/75n98026q01054
- August 19, 2026: Leptin Protein (26-006897) (26-006897), special notice. https://abierto.us/opportunities/26006897
- August 11, 2026: VISN 12 New Blood and Blood Products Contract (36C25226Q0606), solicitation. https://abierto.us/opportunities/36c25226q0606
- August 11, 2026: Japanese Encephalitis Vaccine (JEV) (SPE2DP-26-R-0001), presolicitation. https://abierto.us/opportunities/spe2dp26r0001
- August 7, 2026: custom HuCAL recombinant Fab antibody (75N98026Q00977), solicitation. https://abierto.us/opportunities/75n98026q00977
- August 7, 2026: Human Kinase LentiArray CRISPR Library (75N98026Q00985), solicitation. https://abierto.us/opportunities/75n98026q00985
- August 5, 2026: Notice of Intent to Sole Source: NAIHS OEHE - Rabies Vaccination Purchase (NOI-NAO-26-0001), special notice. https://abierto.us/opportunities/noinao260001
- August 4, 2026: Intent to Sole Source - Endotoxin Detection System Cartridges (NOI-CC-OLAO-26-007979), special notice. https://abierto.us/opportunities/noiccolao26007979
- July 28, 2026: Notice of Intent to Sole Source the Procurement of Weekly Delivery of Turkey, Chicken, Guinea Pig, and Horse Red Blood Cells (75D301-26-R-73503), combined synopsis and solicitation. https://abierto.us/opportunities/75d30126r73503
- July 22, 2026: Purchase of new ChemiDoc™ MP Imaging system from BioRad (75N98026Q00856BIORAD), presolicitation. https://abierto.us/opportunities/75n98026q00856biorad
- July 17, 2026: Reconstructed Human Small Intestine and Human Skin Models Microtissue Samples and Culture Media (75F40126Q132991), combined synopsis and solicitation. https://abierto.us/opportunities/75f40126q132991
- July 17, 2026: (Presolicitation Notice) Intent to Sole Source - BioRad Antibodies (PR-95570), presolicitation. https://abierto.us/opportunities/pr95570
- July 16, 2026: synthesis of prodrug analogs and cyclopentane peptide nucleic acid (PNA) precursors (75N98026Q00819CREAGENINC), presolicitation. https://abierto.us/opportunities/75n98026q00819creageninc
- July 13, 2026: NIST Human Serum Standard Reference Material (SRM) (1333ND26QNB640317), solicitation, awarded to Solomon Park Research Laboratories, Inc.. https://abierto.us/opportunities/1333nd26qnb640317
- July 8, 2026: GMP Grade Human Interleukin-2 (IL-2) from ACROBiosystems Inc. (26-006951), presolicitation, awarded to Acrobiosystems Inc.. https://abierto.us/opportunities/26006951
- June 29, 2026: FMD Vaccine Sources Sought (1166475), sources sought. https://abierto.us/opportunities/1166475
- June 24, 2026: PacBio sequencing reagents (75N98026Q00697), presolicitation, awarded to Pacific Biosciences of California, Inc.. https://abierto.us/opportunities/75n98026q00697
- June 22, 2026: Whole Exome Analysis of NIAAA Clinical Center pATIENTS (75N98026Q00677), presolicitation. https://abierto.us/opportunities/75n98026q00677

---
Sources: SAM.gov Contract Opportunities extract and USAspending.gov award data. Cite https://abierto.us/industries/325414.